Orange Book product · Generic (ANDA)
ROCURONIUM BROMIDE
ROCURONIUM BROMIDE
At a glance
Feb 28, 2017
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Feb 28, 2017
9 yr 5 mo ago
Today
Pharmaceutical detail
Active ingredient
ROCURONIUM BROMIDE
Strength
50MG/5ML (10MG/ML)
Dosage form
INJECTABLE
Route
INJECTION
TE code
AP
Application
ANDA 204679
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of ROCURONIUM BROMIDE
- 2025ROCURONIUM BROMIDEBrand (NDA)
NDA 219108 · B BRAUN MEDICAL
- 2025ROCURONIUM BROMIDEBrand (NDA)
NDA 217472 · FRESENIUS KABI USA
- 1994ZEMURONBrand (NDA)
NDA 020214 · ORGANON USA INC
- 2026ROCURONIUM BROMIDEGeneric (ANDA)
ANDA 220124 · ASPIRO
- 2026ROCURONIUM BROMIDEGeneric (ANDA)
ANDA 213476 · KNACK
- 2025ROCURONIUM BROMIDEGeneric (ANDA)
ANDA 219674 · MANKIND PHARMA
- 2024ROCURONIUM BROMIDEGeneric (ANDA)
ANDA 217092 · STERISCIENCE
- 2024ROCURONIUM BROMIDEGeneric (ANDA)
ANDA 204918 · RISING
- 2024ROCURONIUM BROMIDEGeneric (ANDA)
ANDA 215684 · SHANDONG
- 2023ROCURONIUM BROMIDEGeneric (ANDA)
ANDA 217034 · HIKMA
- 2023ROCURONIUM BROMIDEGeneric (ANDA)
ANDA 213453 · MEITHEAL
- 2023ROCURONIUM BROMIDEGeneric (ANDA)
ANDA 216234 · CAPLIN
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
